Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “AXIS”

72 pharma patents match "AXIS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 72
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 72 pharmaceutical patents matching "AXIS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

72 results for “AXIS” · 30,257 patents in full index Clear search

  1. US 11275080

    Methods for stratifying non-responders to therapies that block PD1/PDL1 axis

    The Regents of the University of California · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  2. US 11261188

    Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel

    PRAXIS PRECISION MEDICINES, INC. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted

  3. US 11230542

    Inhibitors of integrated stress response pathway

    PRAXIS BIOTECH LLC · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  4. US 11191763

    HIV post-exposure prophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  5. US 11166942

    Inhibitors of integrated stress response pathway

    PRAXIS BIOTECH LLC · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  6. US 11014931

    3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator

    PRAXIS PRECISION MEDICINES, INC. · Granted May 25, 2021 · Expires May 20, 2041

    granted

  7. US 10952980

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  8. US 10927141

    Salts and crystal forms of GABAA positive allosteric modulator

    PRAXIS PRECISION MEDICINES, INC. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  9. US 10676452

    Compound for the prophylaxis or treatment of organ damage

    Sulfateq B.V. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  10. US 10662146

    Prodrugs of fencamfamine

    Praxis Bioresearch, LLC · Granted May 26, 2020 · Expires May 21, 2040

    granted

  11. US 10562930

    Salts and crystal forms of GABAA positive allosteric modulator

    PRAXIS PRECISION MEDICINES, INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  12. US 10434078

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  13. US 10335423

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  14. US 10206886

    Lipid nanoparticles for wound healing

    PRAXIS BIOPHARMA RESEARCH INSTITUTE · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  15. US 9937191

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  16. US 9820955

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  17. US 9820970

    Method and agent for the treatment and prophylaxis of diseases caused by (+)RNA-containing viruses

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  18. US 9700562

    Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  19. US 9597276

    Composition for the prophylaxis of candidiasis

    OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NTLAB-SC” · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  20. US 9498544

    Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

    Tissue Regeneration Therapeutics Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  21. US 9334246

    Substituted triazines for malaria treatment and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted May 10, 2016 · Expires May 5, 2036

    granted

  22. US 9200077

    Injectable solution containing therapeutic agent for osteoarthritis

    AXIS · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  23. US 9089531

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  24. US 9044509

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.